Among patients with renal cell carcinoma, those with larger tumors may yield the most benefit from SBRT compared with other ...

vs SBRT alone in patients with metachronous oligorecurrent hormone-sensitive prostate cancer (HSPC). 1 The data were published in Lancet Oncology. In total, the study enrolled 105 patients who were ...

A short course of androgen deprivation therapy (ADT) added to stereotactic body radiotherapy (SBRT) halved the risk of disease progression or death in patients with metachronous oligometastatic ...

Objective: This systematic review aimed to evaluate the impact of sublobar resection (SLR) on the quality of life (QoL) of patients with early-stage non-small cell lung cancer (NSCLC). Specifically, ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

The SBRT arm had significantly prolonged radiographic progression-free survival (rPFS) compared with patients who received enzalutamide plus ADT alone: 4.6 vs 2.3 years, for a significant 52% ...

1 The authors should be congratulated for running this individual patient data meta-analysis on almost 6000 patients ... Whether their conclusions concerning dose-escalated MHFRT hold true in an era ...

Patient experience encompasses the range of interactions that patients have with the healthcare system, including their care from health plans, and from doctors, nurses, and staff in hospitals, ...